Cytodyn, Inc.

This study tested an experimental drug called leronlimab in patients with advanced solid tumors that had a specific marker (CCR5+). The main goals were to check the drug's safety and see if it could help control the cancer. Patients received weekly injections of leronlimab, often…

This study tested an experimental drug called PRO 140 in combination with other HIV medications for people whose current treatments were no longer working well. It involved 6 adults with HIV who had developed resistance to multiple classes of standard drugs. Researchers measured …

This study tested whether a weekly injection called leronlimab could help people hospitalized with severe or critical COVID-19. Nearly 500 participants were randomly assigned to receive either the drug or a placebo shot. Researchers measured if the treatment reduced deaths and he…

This study tested if a weekly injection called PRO 140 could control HIV by itself for 48 weeks, instead of the standard daily pill combinations. It involved 562 adults whose HIV was already well-controlled on daily medications. The goal was to see if switching to just the weekly…